Lupin launches generic joint pain drug in US

The company's product -- Diclofenac Sodium Topical Solution 2% -- is the generic version of Horizon Pharma Therapeutics Pennsaid
By PTI on December 12, 2022

Lupin recently said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.

The company’s product — Diclofenac Sodium Topical Solution 2% — is the generic version of Horizon Pharma Therapeutics Pennsaid, a company statement mentioned.

Diclofenac Sodium Topical Solutiongeneric joint pain drugHorizon Pharma TherapeuticsLupinPennsaid
Related Posts

Sharp spike in pharma, healthcare funding in April 2024, touches $332 mn

Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP

PHARMAP 2024 held in Amsterdam, marks its fourth edition

Research led by Sydney University develop nanotech-based oral insulin medicine

Chinese companies lead ADC development pipeline: GlobalData

Alembic Pharmaceuticals receives an EIR for its oncology formulation facility

Results show potential of J&J’s TAR-210 to transform treatment of bladder cancer with FGFR alterations
Comments (1)
Add Comment
  • soundos

    Thanks for share this post